Cipla news: Cipla eyes acquisitions, inorganic partnerships in US market
Drug main Cipla is eyeing acquisitions and inorganic partnerships within the US market whereas consolidating its presence throughout segments within ...
Drug main Cipla is eyeing acquisitions and inorganic partnerships within the US market whereas consolidating its presence throughout segments within ...
Copyright © 2022 Asia Today.